ProCE Banner Activity

Treatment Options From 5 Experts for Patients With Advanced Endometrial Cancer

Tool

Use this Interactive Decision Support Tool to see treatment recommendations from 5 experts by answering a series of questions about your diagnosis.

Released: November 02, 2023

Share

Faculty

Hye Sook Chon

Hye Sook Chon, MD

Associate Professor
Clinical Trial Medical Director
Department of Gynecologic Oncology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Linda R. Duska

Linda R. Duska, MD, MPH, FACOG, FACS, FASCO

Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia

Ebony Hoskins

Ebony Hoskins, MD

Clinical Assistant Professor 
Obsterics and Gynecology; Gynecologic Oncology 
Georgetown University Medical Center 
Gynecologic Oncology 
WIS
Medstar Washington Hospital Center 
Washington, D.C.

Lauren Prescott

Lauren Prescott, MD, MPH

Assistant Professor, Obstetrics and Gynecology
Division of Gynecologic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee

Ritu Salani

Ritu Salani, MD, MBA

Professor and Division Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from GSK.

GSK

Faculty Disclosure

Primary Author

Hye Sook Chon, MD

Associate Professor
Clinical Trial Medical Director
Department of Gynecologic Oncology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Hye Sook Chon, MD, has no relevant financial relationships to disclose.

Linda R. Duska, MD, MPH, FACOG, FACS, FASCO

Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia

Linda Duska, MD, MPH, FACOG, FACS, FASCO: researcher (paid to institution): Aduro Biotech Inc, ARCH Oncology, CE3 Inc, Clinipace Inc, Corcept Therapeutics, Eisia, GlaxoSmithKline, Harpoon Therapeutics, K-Group Beta, Leap Therapeutics, Lycera, Ludwig Institute for Cancer Research, Merck Sharp and Dohme, NRG, OncoQuest, Pfizer, PharmaMar, Plexxikon, Psi Pharma Support America, Seattle Genetics, Syndax; data safety monitoring committee: Agenus, Inovio.

Ebony Hoskins, MD

Clinical Assistant Professor 
Obsterics and Gynecology; Gynecologic Oncology 
Georgetown University Medical Center 
Gynecologic Oncology 
WIS
Medstar Washington Hospital Center 
Washington, D.C.

Ebony Hoskins, MD, has no relevant financial relationships to disclose.

Lauren Prescott, MD, MPH

Assistant Professor, Obstetrics and Gynecology
Division of Gynecologic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee

Lauren Prescott, MD, MPH, has no relevant financial relationships to disclose.

Ritu Salani, MD, MBA

Professor and Division Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California

Ritu Salani, MD, MBA: consultant/advisor/speaker: GSK, Merck, Regeneron, Seagen.